Impact of Pathologic Complete Response on the Prognosis of Triple-Negative Breast Cancer Patients: A Cohort Study

Introduction Triple-negative breast cancer (TNBC) is a molecular subtype in which estrogen (ER)/progesterone receptor (PR) and human epidermal growth receptor 2 (HER2) expression does not occur. The objective of this study was to analyze the impact of pathologic complete response (pCR) after neoadju...

Descripción completa

Detalles Bibliográficos
Autores principales: Assunção Ribeiro da Costa, Rafael Everton, Rocha de Oliveira, Fergus Tomás, Nascimento Araújo, Ana Lúcia, Vieira, Sabas Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171840/
https://www.ncbi.nlm.nih.gov/pubmed/37182056
http://dx.doi.org/10.7759/cureus.37396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171840/
https://www.ncbi.nlm.nih.gov/pubmed/37182056
http://dx.doi.org/10.7759/cureus.37396

Ejemplares similares